BAMBINO GESÙ Children’s Hospital IRCCS
Children’s Hospital IRCCS, an Institution of the Holy See, is the largest paediatric hospital and research centre in Europe, with its main site in Rome and satellite facilities in the Lazio region. Founded in 1869 as Italy’s first dedicated paediatric hospital, it has been recognised as an IRCCS since 1985 and is internationally accredited for clinical excellence, translational research and training. The hospital serves as a national and international referral centre for children and adolescents, with recognised expertise in paediatric oncology, rare diseases and complex chronic conditions.
Within the European project ON‑COME (paediatric Oncology Network and COmmunication on the Mind‑body‑Environment relationship), Bambino Gesù Children’s Hospital IRCCS participates as a leading centre in paediatric oncology, bringing advanced clinical expertise, translational research and integrated care models to the consortium. The hospital contributes to mapping existing paediatric oncology services and best practices (WP1), defining standards for care and communication with patients and families (WP2), designing and testing integrated clinical‑neuropsychological and psychosocial interventions (WP3), delivering professional training and capacity building (WP4), and assessing psychosocial and quality‑of‑life outcomes (WP5). In ON‑COME, Bambino Gesù supports the development of a standardised, sustainable and replicable model of care across European health systems.
- WP1 – Mapping paediatric oncology services and best practices
- WP2 – Standardisation of communication and paediatric care
- WP3 – Development and implementation of integrated clinical‑neuropsychological and psychosocial interventions
- WP4 – Training of professionals and capacity building
- WP5 – Clinical implementation and evaluation of outcomes
UoA – National and Kapodistrian University of Athens
From Greece, the project is represented by the Pediatric Oncology-Hematology Unit of the 1st Department of Pediatrics, National and Kapodistrian University of Athens. Prof. Antonis Kattamis is the Principal Investigator (PI) and main contact. The team includes Savina Pantazopoulou (neuropsychologist, project coordination), Dr. Ilona Binenbaum (bioinformatician, data manager), and Evangelia Pafili (social worker).
The Unit provides comprehensive care and support to children and adolescents with hematological and oncological diseases. We additionally provide surveillance and care for children and adolescents with cancer predisposition syndromes. Facilities include inpatient and outpatient services and a dedicated translational laboratory.
Our team will participate in several work packages within the ON-COME project, starting with WP2, where we are involved in the mapping of psycho-oncological services in Greece and Cyprus, identifying gaps and implementing a standardised blueprint for the oncological patient journey.
In WP3, we will support the development of the common data model and architecture, and will provide both retrospective data (such as existing neuropsychological assessments) and collect prospective data for AI model training.
Several members of our team will take part in trainings organised through WP4, mainly for the enhancement of psychosocial support skills promoting the use of digital tools among healthcare professionals.
Finally, in WP5, our team will participate in the piloting of the Unified Service System developed through ON-COME. We look forward to contributing to the implementation of newly developed care services and to the adoption of digital tools, with the aim of improving patients’ quality of life and supporting their neuropsychological rehabilitation. We will also participate in the active monitoring of pilot outcomes and in ensuring the sustainability of the implemented care services.
The Italian Federation of Cancer Patients’ Organizations (FAVO)
The Italian Federation of Cancer Patients’ Organizations (FAVO) was founded in 2003 as an “association of associations” dedicated to supporting cancer patients and their families. In 2025 FAVO became an Associative Network recognized by RUNTS (the National Registry of the Third Sector). The Federation, managed by an Executive Committee composed mainly of current or former patients, comprises over 300 associations, many of which are spread throughout the country with representatives in every province, for a total of approximately 20,000 volunteers (mostly current or former patients) and 600,000 members in various capacities.
The member associations operate within Cancer Centers and healthcare facilities, or in separate offices; they assist adult or paediatric patients, offering a wide range of different services. Whatever the specific characteristics and missions of the associations, they are united by a common motto: “Healing is possible; ensuring the best possible quality of life for patients is a must.”
Within the European project ON-COME (paediatric Oncology Network and COmmunication on the MindbodyEnvironment relationship), FAVO plays an important role in bringing the patients’ point of view at the core of the project activities. In particular, FAVO actively contributes to:
- Mapping and Standardization of the Unified Psycho-Oncological Services (WP2).
- Digital Tools & Services Development (WP3), ensuring accessibility and ease of navigation.
- Piloting and Implementation: Participates in the pilot phase of new services and the adoption of digital tools in clinical settings (WP5).
- Analysis of Behavioral Change: It supports the study of psychological and cultural barriers to facilitate the adoption of innovative tools by patients and families (WP5).
- Dissemination and Outreach: Thanks to its extensive network of associations, FAVO is essential for disseminating results, engaging stakeholders, and influencing national and European health policies (WP6).
Datawizard
Datawizard is an Italian SME active in the Digital Health sector, focused on enabling patient-centred healthcare through service design, data science and digital solutions. Founded in 2012 by experts from industry and healthcare, the company brings together multidisciplinary expertise in digital health development, UX/UI design, data analytics, innovation management and project financing. Since its establishment, Datawizard has built a strong network of European partners, including healthcare providers, research institutions, universities, MedTech and pharmaceutical companies, contributing to the development of innovative and scalable digital health solutions.
Within the European project ON-COME, Datawizard acts as a digital enabler and technology partner, supporting the integration of user needs into technical solutions through a user-centred approach. The company contributes to the definition of a standardised and holistic service blueprint (WP2) and to the design and development of the system architecture and applications (WP3), including back-end infrastructure and user interfaces for patients and healthcare professionals. Datawizard also supports tool testing and training activities (WP4), contributes to the evaluation of user adoption and outcomes (WP5), and plays a key role in exploitation and innovation activities (WP6). In ON-COME, Datawizard oversees the development cycle from requirements definition to system validation and adoption.
- WP2 – Definition of a standardized and holistic service blueprint
- WP3 – Design of system specifications and development of the back-end architecture and user applications
- WP4 – Support to tool testing and training of healthcare professionals (HCPs)
- WP5 – Analysis of user adoption and evaluation of outcomes
- WP6 – Exploitation and innovation management
University of Milan (UMIL)
Founded in 1924, the University of Milan (UMIL) is a leading public research university in Italy, with a strong focus on medicine and surgery and a solid track record in clinical and translational research. Closely integrated with major healthcare infrastructures, including university hospitals and clinical research centers, UMIL supports high-impact biomedical innovation. In recent years, the university has strengthened its initiatives in psychological sciences, promoting their integration within medical settings through interdisciplinary programs combining neuroscience, clinical psychology, and healthcare. UMIL is actively involved in national and international projects aimed at improving clinical outcomes through innovative diagnostic tools, rehabilitation strategies, and digital health solutions, advancing integrated and personalized models of care.
UMIL contributes its expertise in cognitive rehabilitation, neuropsychology, and psycho-oncology, with a specific focus on patients experiencing cognitive impairments related to cancer and its treatments. UMIL supports the mapping and standardization of psycho-oncological and neuropsychological services (WP2), contributing to the identification of gaps and to the development of a unified, multidisciplinary rehabilitation framework. It also contributes to WP3 by supporting the development of digital tools and data infrastructures, with particular emphasis on the integration of cognitive rehabilitation and assessment. Furthermore, UMIL is actively involved in training activities (WP4), providing expertise in cognitive rehabilitation and participates in pilot implementation and outcome evaluation (WP5). Finally, UMIL contributes to dissemination (WP6), supporting the translation of project results into sustainable and scalable healthcare practices across Europe.
- WP2 – Mapping and standardization of psycho-oncological services
- WP3 – Digital tools and services development
- WP4 – Training and skills enhancement of healthcare professionals
- WP5 – Piloting of the unified service system and outcome monitoring
- WP6 – Dissemination, outreach and policy impact
Charité – Universitätsmedizin Berlin
Charité – Universitätsmedizin Berlin was founded in 1710 and is one of the largest and most renowned medical institutions in Europe. It combines research, teaching, and patient care. Each year, approximately 850,000 patients receive treatment in more than 100 disciplines. In pediatric oncology, about 120 children are treated annually by a dedicated multidisciplinary team.
At ON-COME, Charité is leading work package 5 (WP5). This work package focuses on implementing and evaluating psychosocial, neuropsychological, and nutritional support services within the ON-COME project. It includes a pilot phase for development and an interventional phase to assess their impact on pediatric oncology patients and their families, involving continuous monitoring of patient outcomes and ensuring full compliance with ethical guidelines throughout the project. Further Charité contributes to the mapping of capabilities and identifying gaps (WP2), development of an unified service system (WP3), nutritional skills development and training on digital tools for HCP (WP4) and supporting the visibility of the project (WP6).
- WP2- Mapping Capabilities and Identifying Gaps.
- WP3 - Digital Tools and Services Development
- WP4 - Training and Skills Enhancement of HCPs
- WP5 - Piloting of the Unified Service System
- WP6 - Dissemination and Communication
EAPM - The European Alliance for Personalised Medicine
The European Alliance for Personalised Medicine (EAPM) is a Brussels-based multi-stakeholder organisation dedicated to advancing personalised healthcare and innovation across Europe through policy dialogue, stakeholder engagement, and collaboration between patients, healthcare professionals, researchers, industry, regulators, and policymakers. Established in 2012, EAPM works at the intersection of science, policy, and healthcare implementation, supporting the integration of innovative approaches into sustainable and equitable health systems. The Alliance has extensive experience coordinating dissemination, communication, and policy engagement activities within European collaborative projects, particularly in the fields of oncology, diagnostics, digital health, and personalised medicine.
Within the European project ON-COME (paediatric Oncology Network and Communication on the Mind-body-Environment relationship), EAPM leads Work Package 6 on dissemination, communication, stakeholder engagement, and policy outreach. EAPM supports the visibility and long-term sustainability of the project by coordinating communication activities, managing stakeholder engagement strategies, and facilitating dialogue between healthcare professionals, patient representatives, policymakers, and institutional actors across Europe.
In ON-COME, EAPM contributes to the development and dissemination of project outputs and policy recommendations, supports the organisation of public events and stakeholder consultations, and promotes the integration of psychosocial, neuropsychological, and nutritional dimensions into broader European discussions on paediatric cancer care. Through its network and policy expertise, EAPM also supports the establishment and future positioning of the ON-COME Alliance at European level, fostering collaboration and knowledge exchange among relevant stakeholders and initiatives.
WP6 – Dissemination, communication, stakeholder engagement and policy outreach
CATTOLICA Università Cattolica del Sacro Cuore
Università Cattolica del Sacro Cuore (UCSC) is one of Italy's largest and most prestigious universities, with campuses in Rome, Milan, Brescia, Piacenza and Cremona. Founded in 1921, UCSC combines academic excellence across medicine, psychology, law, economics and humanities with a strong vocation for applied and translational research. The Faculty of Medicine and Surgery, located in Rome and fully integrated with Fondazione Policlinico Universitario Agostino Gemelli IRCCS, is among Italy's foremost clinical and research training environments. UCSC has established expertise in clinical psychology, neuropsychology, psycho-oncology, health communication and digital health innovation.
Within the European project ON‑COME (paediatric Oncology Network and COmmunication on the Mind‑body‑Environment relationship), Università Cattolica del Sacro Cuore acts as the project coordinator, providing scientific leadership and consortium governance throughout the duration of the action. UCSC leads the overall strategic direction of the project and contributes substantive expertise across all work packages.
The university plays a central role in mapping existing psychosocial, neuropsychological and nutritional services across Europe and identifying gaps in care (WP2), in the development of digital tools — including an AI-powered patient‐caregiver application and a healthcare professional platform — to support personalised and integrated care delivery (WP3), in designing and delivering specialised training programmes for healthcare professionals (WP4), in piloting and evaluating the newly developed services in clinical settings (WP5), and in disseminating results and translating project outcomes into evidence‐based policy recommendations (WP6).
- WP1 – Project management and coordination (lead)
- WP2 – Mapping of psychosocial, neuropsychological and nutritional services and best practices
- WP3 – Development of digital tools and AI-powered patient and HCP platforms
- WP4 – Training of healthcare professionals and capacity building
- WP5 – Piloting and clinical evaluation of integrated services
- • WP6 – Dissemination, outreach and policy impact
GEMELLI Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is one of Italy's premier university hospitals and a nationally designated IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico). Located in Rome and organically integrated with Università Cattolica del Sacro Cuore, it serves as a major national and international referral centre for complex, rare and oncological conditions. Recognised for clinical excellence, cutting‐edge translational research and specialised training, the Gemelli hospital combines advanced diagnostic and therapeutic capabilities with strong multidisciplinary and psychosocial care models. Its paediatric oncology services bring together haematology‐oncology, neuro‐oncology, neuropsychology, clinical psychology, rehabilitation and family support within a fully integrated care pathway.
Within the European project ON‑COME (paediatric Oncology Network and COmmunication on the Mind‑body‑Environment relationship), Fondazione Policlinico Universitario Agostino Gemelli IRCCS participates as the leading clinical partner and second beneficiary, contributing advanced paediatric oncology expertise, established psychosocial and neuropsychological services, and translational research capabilities to the consortium.
FPG leads WP2, which is dedicated to mapping current psychosocial, neuropsychological, and nutritional care practices and identifying service gaps across participating countries. FPG also plays a key role in informing the design and clinical validation of AI-powered digital tools for patients, caregivers, and healthcare professionals (WP3); delivering specialised training for healthcare professionals (WP4); piloting and evaluating the integrated service model in a real clinical setting (WP5); and disseminating evidence and contributing to European policy recommendations on paediatric supportive care (WP6).
- WP1 – Project management and coordination
- WP2 – Mapping of psychosocial, neuropsychological and nutritional services and best practices (lead)
- WP3 – Development of digital tools and AI-powered patient and HCP platforms
- WP4 – Training of healthcare professionals and capacity building
- WP5 – Piloting and clinical evaluation of integrated services
- WP6 – Dissemination, outreach and policy impact
HOSPICES CIVILS DE LYON
The Hospices Civils de Lyon (HCL) is the second largest university hospital network in France and one of the leading public centres of excellence in Europe. Bringing together 14 multidisciplinary and specialised hospitals, HCL provides comprehensive care across all medical and surgical disciplines and is internationally recognised for its expertise in neurosciences, genetics, oncology and rare diseases. Ranked among the 25 best hospitals in the world, HCL combines clinical excellence, research, innovation, education and prevention through a network of more than 23,000 professionals. For more than 200 years, HCL has contributed to the continuous improvement of healthcare through advanced patient care, medical research, training and public health initiatives. The paediatric neurosurgery department at HCL is dedicated to the diagnosis and treatment of complex conditions in children, offering cutting-edge surgical techniques and multidisciplinary care tailored to young patients. This service plays a key role in advancing paediatric neurosurgical research and improving outcomes for children both locally and internationally. More information is available through Hospices Civils de Lyon.
Within the European project ON-COME (paediatric Oncology Network and COmmunication on the Mind-body-Environment relationship), the pediatric neurosurgery department from the Hospices Civils de Lyon participates as a major clinical and academic partner contributing to the development of an integrated and standardised model of paediatric oncology care across Europe. HCL contributes to the mapping and harmonisation of psychosocial, neuropsychological and nutritional care services (WP2), the development of patient-centred and digital supportive care approaches (WP3), and the implementation and evaluation of integrated psychosocial and quality-of-life interventions (WP5).
HCL leads Work Package 4 (WP4) dedicated to the Training and Skills Enhancement of Healthcare Professionals (HCPs). HCL also contributes to dissemination, networking and sustainability activities within WP6, supporting the development of the ON-COME Alliance and the long-term implementation of innovative and replicable models of paediatric oncology care across European health systems.
UNIVERSIDAD POLITÉCNICA DE MADRID
The Universidad Politécnica de Madrid (UPM) is a leading Spanish technical university specialising in engineering, architecture, and technology. Founded in 1971, it integrates some of Spain’s oldest and most prestigious engineering schools. UPM is renowned for its high-quality research, innovation, and industry collaborations, particularly in areas such as aerospace, telecommunications, robotics, and sustainability. The university consistently ranks among the top technical universities in Europe and maintains strong international partnerships with academic institutions and companies worldwide.
As technical leaders, UPM’s main role in the project is the supervision of all technical developments and data management activities, as well as the joint design and implementation, together with other technical partners, of the main federated network for data access and sharing, including AI-based developments.
WP1, WP2, WP3 (Leaders, main contribution), WP4, WP5, WP6